P-type IID ATPase-encoding genes as an antifungal target for the treatment of aspergillus fumigatus
Keywords:
Aspergillus fumigatus; ATPase P-Type IID; antifungal; narrative literature review; coding genesAbstract
Introduction: Aspergillus fumigatus is the main filamentous fungus causing invasive aspergillosis in patients with significant deficits in cell-mediated immunity.
Objective: The study aimed to analize P-Type IID ATPase-encoding genes as an antifungal target for the treatment of Aspergillus fumigatus by means of a narrative literature review.
Methods: A narrative literature review was developed, since it was a study that focused on the critical review of the existing literature and the synthesis of the results on P-Type IID ATPase-encoding genes as an antifungal target for the treatment of Aspergillus fumigatus, in a coherent argument, being a retrospective and descriptive study.
Results: It was evidenced that P-Type IID ATPases are important proteins found in Aspergillus fumigatus; furthermore, the development of effective antifungal therapies against Aspergillus fumigatus is critical due to the resistance it has developed to current treatments. Treatment for Aspergillus fumigatus infection was found to be generally based on the use of antifungals, such as voriconazole, itraconazole, or amphotericin B. It may also include elimination of any source of infection. It may also include elimination of any source of exposure to the fungus.
Conclusions: A solid basis was provided for the identification of areas of research that need to be explored in more detail. It is suggested that inhibition of P-Type IID ATPase-encoding genes may be a promising strategy for the treatment of Aspergillus fumigatus. Further studies are needed to evaluate the efficacy of these strategies in clinical trials.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0), which allows others to share the work provided that its authorship and initial publication in this journal are acknowledged. Authors may enter into separate, additional agreements for the non-exclusive distribution of the published version of the work (e.g., posting it to an institutional repository or publishing it in a book), provided that its initial publication in this journal is acknowledged. Authors are permitted and encouraged to share their work online (e.g., in institutional repositories or on their personal website) before and during the submission process, as this can lead to productive exchanges and increase citation of the published work (see The Effect of Open Access).
As the Revista Cubana de Investigaciones Biomédicas is part of the SciELO network, once articles have been accepted into the editorial process (peer review), authors may, if they agree, deposit them in SciELO Preprints and update them there once the review process and layout proofs are complete.
